Latest Content

Clark Chang, OD, MSA, MSc, FAAO, FSLS, and Susan Gromacki, OD, MS, FAAO, FSLS, provide insights into their expertise.

The strength of our referral relationships defines the quality of our patients' eye health journey.

Mile Brujic, OD, FAAO, details his experience in manufacturing his new ScleralEase device and what other ODs can learn from his experience.

Researchers from Yale School of Medicine weigh in on what everyday clinicians can take away from their findings.

Myopia management is rarely straightforward.

The topical synthetic peptide receives orphan drug and fast track status and enters phase 2 as a first-in-class treatment for a rare degenerative corneal disease.

Yale School of Medicine researchers outline their findings and the methods of their researcher in an exclusive interview with Optometry Times.

A pilot study shows that analyzing how the cornea moves under air-puff stimulation may improve early keratoconus detection.

The university received $29.8 million through the state's Amended Fiscal Year 2026 Budget to renovate the Highway 301 building in Statesboro and create a facility to house the new program.

The resubmission follows a successful appeal by the company with the Office of New Drugs (OND).

Host Hamza Shah, OD, MS, FAAO, is joined by Kaleb Abbott, OD, MS, to discuss eye care terminology, inspired by Abbott and Pucker's paper, "It's time to retire the terms artificial tears and rewetting drops: A call for accurate terminology and updated clinical usage in eye care."

The benefits of consistent physical activity have been demonstrated for a host of systemic conditions.

Kevin J. Kovach, MD, and Giannie Castellanos, OD, gave their insights this season on what helps build referral trust and long-lasting comanagement relationships.